Clinical pharmacology of celecoxib, a COX-2 selective inhibitor

By Antoniou Katerina   Malamas Michael   Drosos Alexandros A  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1719-1732

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacology of Novel Selective COX-2 Inhibitors

By  

Current Pharmaceutical Design, Vol. 10, Iss. 6, 2004-02 ,pp. : 589-601

Bentham Science Publishers

Access to resources Recommend Favorite

The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment

By Lima-Rodrigues Manuel   Lamas Nuno   Valle-Fernandes Ana   Cruz Andrea   Vieira Artur   Oliveira Pedro   Pedrosa Jorge   Castro António   Reis Rui   Baltazar Fátima   Almeida Armando  

Inflammation Research, Vol. 59, Iss. 9, 2010-09 ,pp. : 743-753

Springer Publishing Company

Access to resources Recommend Favorite

Clinical pharmacology of etoricoxib

By Capone Marta L   Tacconelli Stefania   Patrignani Paola  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 2, 2005-08 ,pp. : 269-282

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacology of Lumiracoxib: A Selective Cyclo-Oxygenase-2 Inhibitor

By Rordorf Christiane M.  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1247-1266

Adis International

Access to resources Recommend Favorite